Leukemia in bipolar mood disorder: is lithium contraindicated?

Area of Science:

• Psychiatry and Hematology
• Pharmacology and Toxicology

Background:

• Lithium is known to cause leukocytosis (elevated white blood cell count).
• Concerns exist that lithium may stimulate leukemic cells, potentially causing leukemia development.
• These concerns are primarily based on anecdotal reports and in vitro research.

Purpose of the Study:

• To evaluate the association between lithium use and the development of leukemia.
• To synthesize existing evidence regarding lithium's potential leukemogenic effects.

Main Methods:

• Review of anecdotal case reports.
• Analysis of in vitro studies.
• Examination of epidemiological studies and in vivo data.

Main Results:

• In vitro studies and case reports suggest a potential link between lithium and leukemia.
• Epidemiology studies and in vivo data do not support this association.
• Current evidence is insufficient to confirm lithium as a cause of leukemia.

Conclusions:

• The link between lithium and leukemia development remains unsubstantiated.
• Further comprehensive research is needed to definitively assess the risk, if any.
• Existing data do not warrant a definitive conclusion on lithium's leukemogenic potential.